Back to Agenda
Session 2: Navigating Advertising and Promotion: Multi-Center Updates from FDA
Session Chair(s)
Twyla Mosey, PHARMD
Acting Office Director, OPDP, CDER , FDA, United States
Gain firsthand insights from FDA experts on compliance priorities and best practices shaping the future of compliant advertising and promotion.
OPDP Updates
Twyla Mosey, FDA
Updates in Advertising & Promotion: FDA CBER APLB
Kristine T. Khuc, FDA
FDA, Center for Veterinary Medicine: FDA Updates and Insights
Christopher Loss, FDA
FDA, Center for Veterinary Medicine: FDA Updates and Insights
Deborah Wolf, FDA
Learning Objective : At the conclusion of this session, participants should be able to:- Identify current compliance priorities in advertising and promotion and explain how these priorities apply across different FDA-regulated product categories
- Analyze recent compliance actions and extract key lessons learned to achieve regulatory compliance
- Describe and implement strategies for continued compliance across FDA-regulated products
Speaker(s)
OPDP Updates
Acting Office Director, OPDP, CDER , FDA, United States
Updates in Advertising & Promotion: FDA CBER APLB
Consumer Safety Officer, CBER, FDA, United States
FDA, Center for Veterinary Medicine: FDA Updates and Insights
Supervisory Veterinary Medical Officer (Branch Chief), FDA, United States
Center for Devices and Radiological Health
Regulatory Counsel, OPEQ , Regulatory Policy, CDRH, FDA, United States
Have an account?
